908 Devices (MASS)
Builds handheld instruments that identify hazardous chemicals at the point of need.
$10.39
Pre-market+0.05 (+0.48%)
At close$10.34(−2.91%)
In millions of USD, except per-share figures
| In millions | Q3 FY23Sep 2023 | Q4 FY23Dec 2023 | Q1 FY24Mar 2024 | Q2 FY24Jun 2024 | Q3 FY24Sep 2024 | Q4 FY24Dec 2024 | Q1 FY25Mar 2025 | Q2 FY25Jun 2025 | Q3 FY25Sep 2025 | Q4 FY25Dec 2025 | Q1 FY26Mar 2026 | Q2 FY26Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 14 | 14 | 7 | 11 | 15 | 19 | 12 | 13 | 14 | 17 | 13 | 16 |
| Cost of revenue | 6 | 7 | 4 | 5 | 7 | 10 | 6 | 7 | 7 | 9 | 7 | 8 |
| Gross profit | 8 | 7 | 4 | 6 | 8 | 9 | 6 | 6 | 7 | 9 | 6 | 8 |
| 17 | 17 | 11 | 15 | 32 | 29 | 17 | 22 | 12 | 12 | 13 | 21 | |
| Research & development | 6 | 5 | 3 | 4 | 4 | 7 | 4 | 4 | 3 | 3 | 3 | 4 |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 9 | 9 | 10 | 11 | |
| General & administrative | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 11 |
| Other expenses | 11 | 12 | 8 | 11 | 28 | 23 | 13 | 17 | 0 | 0 | 0 | 6 |
| Operating income | −9 | −10 | −8 | −9 | −24 | −20 | −11 | −15 | −6 | −3 | −7 | −13 |
| 2 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | −9 | 7 | −5 | 1 | |
| Interest income | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 |
| Other non-operating income | 0 | 0 | −2 | −1 | −18 | −10 | −2 | −7 | 9 | −7 | 5 | −1 |
| Income before tax | −7 | −7 | −6 | −8 | −24 | −20 | −10 | −13 | −15 | 4 | −12 | −12 |
| Income tax expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income from continuing operations | −7 | −7 | −6 | −8 | −24 | −19 | −10 | −13 | −15 | 4 | −12 | −12 |
| Discontinued operations | 0 | 0 | −5 | −5 | −6 | 0 | 53 | 0 | 0 | 0 | 0 | 0 |
| Net income | −7 | −7 | −11 | −13 | −29 | −19 | 44 | −13 | −15 | 4 | −12 | −12 |
| EPS, basic | −$0.22 | −$0.23 | −$0.33 | −$0.37 | −$0.68 | −$0.57 | $1.23 | −$0.37 | −$0.41 | $0.12 | −$0.32 | −$0.32 |
| EPS, diluted | −$0.22 | −$0.23 | −$0.33 | −$0.37 | −$0.68 | −$0.57 | $1.23 | −$0.37 | −$0.41 | $0.10 | −$0.32 | −$0.32 |
| Weighted average shares, basic | 32 | 32 | 33 | 34 | 35 | 35 | 35 | 36 | 36 | 36 | 37 | 38 |
| Weighted average shares, diluted | 32 | 32 | 33 | 34 | 35 | 35 | 35 | 36 | 36 | 39 | 37 | 38 |
| EBITDA | −8 | −10 | −5 | −7 | −5 | −9 | −7 | −7 | −14 | 5 | −11 | −11 |
| Depreciation & amortization | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| EBIT | −9 | −10 | −6 | −8 | −6 | −10 | −9 | −8 | −15 | 4 | −12 | −12 |
